Rabeprazole induced Fixed Drug Eruption: A rare case report by O, Balaji et al.
Vol 10, Issue 5, 2017
Online - 2455-3891 
Print - 0974-2441
RABEPRAZOLE-INDUCED FIXED DRUG ERUPTION: A RARE CASE REPORT
BALAJI O1, AMITA D1, NAVIN PATIL2*
1Department of Pharmacology, Kasturba Medical College, Manipal, Karnataka, India. 2Department of Medical Oncology, Kasturba Medical 
College, Manipal, Karnataka, India. Email: navin903@gmail.com
Received: 16 January 2016, Revised and Accepted: 28 February 2017
ABSTRACT
Among cutaneous adverse drug reactions, fixed drug eruption is the most common cutaneous drug reaction among the Indian population. The drugs 
most commonly implicated in fixed drug eruption are analgesics and antibiotics. Here, we report a case of fixed drug reaction caused by rabeprazole.
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INTRODUCTION
An adverse reaction is defined as an appreciably harmful or unpleasant 
reaction, resulting from an intervention related to the use of a 
medicinal product, which predicts hazard from future administration 
and warrants prevention or specific treatment, or alteration of the 
dosage regimen, or withdrawal of the product. Most common among 
them is cutaneous adverse drug reactions [1] with fixed drug eruption 
being the most common cutaneous drug reaction among the Indian 
population [2]. The drugs most commonly implicated in fixed drug 
eruption are analgesics and antibiotics [2]. Here, we report a case of 
fixed drug reaction caused by rabeprazole.
CASE REPORT
Informed consent was obtained from the patient. A 26-year-old 
male came with complaints of rounded reddish erythematous bright 
red macular patches over the right thumb of size 1 cm × 1 cm, right 
index finger of size 0.5 cm × 0.5 cm, and mucosa of the upper lip of 
size 2 cm × 2 cm with edematous plaques. Patient also had tingling 
and burning sensation with itching. Past history of patient reveals on 
and off fever, cough, and expectoration since 3 months and treatment 
with paracetamol and rabeprazole. Patient said similar lesion 
appeared over his index finger and it subsided after he finished his 
course of treatment. He did not report it to a physician. There is no 
other significant medical history or exposure to other drugs. Two 
weeks back, patient was treated for the same condition with Dolo 
650 mg thrice daily and rabeprazole 20 mg twice daily. After taking 
medications for 1 day, the patient developed reddish macules, and 
doctor advised her to stop rabeprazole. She was then continued 
with paracetamol, and patient lesion slowly subsided on treatment. 
Rechallenge was not performed as the patient did not give consent, and 
causality assessment was performed using Naranjo’s scale. Severity 
and preventability assessment was performed using Hartwig’s scale 
and Thornton’s scale, respectively.
DISCUSSION
In 1894, Brocq coined the term fixed drug eruption (“erytheme  pigmente 
fixe”) after investigating three patients on antipyrine presenting with 
erythematous pigmented eruptions [3]. A fixed drug eruption is a skin 
lesion characterized by bright red, rounded erythematous macules with 
edematous plaques that appear at the same site within 30 minutes to 
12 hrs after the administration of the causative drug. Lesions are usually 
solitary initially and then later after repeated exposure can present as 
multiple lesions occurring at the same site of increasing size as well 
as new lesions over other sites. Common sites of involvement include 
hand, feet, genitalia, periorbital, perioral, and perineal areas [4].
Pathogenesis mainly involves infiltration of the CD8 cells into the 
epidermis, and an intellectual memory is created. When the offending 
drug is administered, these cytotoxic cells gets activated and produce 
a cascade of inflammatory cytokines mainly interferon-alpha [3]. 
These cytokines cause apoptosis of keratinocytes leading to epidermal 
injury presenting as eczema, macules, blisters, and plaques. Acute 
stage is characterized by epidermal necrosis progressing with dermal 
lymphocytic infiltration ultimately resulting in deposition of melanin in 
epidermis in chronic lesions [4].
Many drugs cause fixed drug eruptions, and common ones are included 
in Table 1 [4]. Rabeprazole is a substituted benzimidazole, a proton-
pump inhibitor [5]. It is mainly used in the treatment of peptic ulcer, 
gastroesophageal disorder, and also in Helicobacter pylori infections. 
It causes adverse effects such as diarrhea, headache, dizziness, and 
confusion with the prevalence of cutaneous reactions ranging from 
0.5% to 1.5%. Cutaneous reactions present as angioedema, urticaria, 
anaphylaxis, maculopapular rashes, hyperpigmentation, erythema 
multiforme and erythroderma, exfoliative dermatitis, and bullous 
eruption [4].
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NSAIDs: Nonsteroidal anti-inflammatory drugs, ACE: Angiotensin-converting 
enzyme
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As per literature, only a few cases of fixed drug eruptions have been 
reported with proton-pump inhibitors mainly omeprazole [6-9]. In our 
patient, rabeprazole was given and other drugs causing it was ruled 
out. Causality, severity, and preventability assessment as per Naranjo’s, 
Hartwig’s, and Thornton’s scale was found to be probable, mild severity, 
and not preventable, respectively (Table 2) [10].
CONCLUSION
Since a probable causal relationship is established and rabeprazole 
being a commonly prescribed drug for peptic ulcer disease, 
history of previous drug exposure and any cutaneous adverse drug 
reactions to proton-pump inhibitors should be recorded. Immediate 
discontinuation of drug is warranted if the patient complaints of fixed 
drug eruption and proper treatment should be given. This case also 
suggests increased need for improved post-marketing surveillance 
to combat the emergence of new adverse drug reactions attributed 
to changing trends in drug utilization. Further retrospective as well 
prospective clinical trials can be undertaken to find out the exact 
incidence and prevalence of fixed drug eruptions with proton-pump 
inhibitors in future in India.
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Table 2: Adverse drug reaction assessment
Naranjo’s scale Probable
Hartwig’s scale Mild severity
Thornton’s scale Not preventable
